Facilitators of Multiple Myeloma Treatment: A Qualitative Study

Stefanie Blejec

Rose Cytryn

Radhi Yagnik

Nina A. Bickell

Jenny J. Lin

cancer, multiple myeloma, oncology, qualitative research, treatment facilitators
ONF 2023, 50(3), 372-380. DOI: 10.1188/23.ONF.372-380

Objectives: To examine factors that lead to the facilitation of multiple myeloma (MM) treatment.

Sample & Setting: 29 patients who had been diagnosed with MM at Mount Sinai Hospital in New York City.

Methods & Variables: Semistructured qualitative interviews were administered by trained research staff. Interview topics included illness beliefs, illness experiences, treatment experiences, and treatment decision-making. Interviews were audio recorded and transcribed verbatim. Four coders independently coded the transcripts, and the authors analyzed data using interpretive description.

Results: The following facilitators of treatment were identified: (a) healthcare team trust and support, (b) personal resilience and initiative-taking, and (c) external support (emotional/social support and instrumental/organizational support). Healthcare team trust and support were established through rapport-building and compassion, accessibility and time spent with the patient, shared decision-making, and provider reputation. Personal resilience was manifested by patients through positive attitudes, taking control of their illness, and self-advocacy.

Implications for Nursing: Understanding factors that facilitate MM treatment may lead to better patient outcomes and can potentially inform oncology nursing practice by providing a framework for tailored health education and care management practices for patients with MM.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.